Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.39 - $1.69 $202,255 - $876,442
518,605 New
518,605 $202,000
Q4 2022

Feb 14, 2023

BUY
$2.09 - $4.32 $11.4 Million - $23.6 Million
5,464,082 Added 176.68%
8,556,656 $19.8 Million
Q3 2022

Nov 14, 2022

SELL
$2.24 - $4.18 $134,438 - $250,871
-60,017 Reduced 1.9%
3,092,574 $8.44 Million
Q2 2022

Aug 15, 2022

BUY
$2.85 - $7.77 $8.93 Million - $24.3 Million
3,133,605 Added 16504.82%
3,152,591 $8.98 Million
Q4 2021

Feb 14, 2022

SELL
$8.73 - $15.27 $1.17 Million - $2.05 Million
-134,399 Reduced 87.62%
18,986 $166,000
Q3 2021

Nov 15, 2021

BUY
$13.52 - $23.95 $1.77 Million - $3.13 Million
130,799 Added 579.12%
153,385 $2.13 Million
Q2 2021

Aug 16, 2021

SELL
$22.12 - $32.06 $2.26 Million - $3.28 Million
-102,248 Reduced 81.91%
22,586 $546,000
Q1 2021

May 17, 2021

BUY
$26.12 - $52.17 $192,426 - $384,336
7,367 Added 6.27%
124,834 $4 Million
Q4 2020

Feb 16, 2021

BUY
$14.05 - $29.0 $1.65 Million - $3.41 Million
117,467 New
117,467 $2.89 Million
Q3 2020

Nov 16, 2020

SELL
$14.17 - $19.48 $527,109 - $724,636
-37,199 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$13.25 - $21.72 $612,653 - $1 Million
-46,238 Reduced 55.42%
37,199 $601,000
Q1 2020

May 14, 2020

SELL
$9.73 - $24.9 $1 Million - $2.56 Million
-102,788 Reduced 55.2%
83,437 $1.2 Million
Q4 2019

Feb 14, 2020

BUY
$14.22 - $23.38 $2.06 Million - $3.39 Million
144,859 Added 350.19%
186,225 $3.93 Million
Q3 2019

Nov 14, 2019

BUY
$22.93 - $41.06 $948,522 - $1.7 Million
41,366 New
41,366 $948,000
Q4 2018

Feb 14, 2019

SELL
$26.22 - $56.89 $564,070 - $1.22 Million
-21,513 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$24.31 - $52.74 $522,981 - $1.13 Million
21,513 New
21,513 $1.05 Million

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $3.12B
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.